GLP-1 Medications and Anesthesia: What You Need to Know
hi-doctor.ai BlogApril 6, 2026

GLP-1 Medications and Anesthesia: What You Need to Know

Table of contents

Key Point 1GLP-1 receptor agonists, used for weight loss and diabetes, can affect gastric emptying and increase the risk of pulmonary aspiration during anesthesia.

Key Point 2Current guidelines suggest that patients should consider discontinuing GLP-1 medications several days before undergoing elective surgery to reduce these risks.

Key Point 3It is crucial to inform your healthcare providers, including your anesthesiologist and prescribing doctor, about your GLP-1 medication use before any surgical procedure.

Key Point 4Hi Doctor AI offers a convenient way to consult with EU-licensed doctors regarding your GLP-1 prescriptions and how to manage them around surgical procedures.

Understanding GLP-1 Medications

GLP-1 receptor agonists are a class of medications primarily used to treat type 2 diabetes and, increasingly, for weight management. These drugs mimic the effects of the naturally occurring hormone GLP-1 (glucagon-like peptide-1), which plays a crucial role in regulating blood sugar levels and appetite. Common examples include semaglutide (Wegovy, Ozempic), liraglutide (Saxenda), and tirzepatide (Mounjaro). These medications work by:

  • Stimulating insulin release when blood sugar levels are high.
  • Inhibiting glucagon secretion, which reduces glucose production in the liver.
  • Slowing down gastric emptying, which helps to control appetite and food intake.

The slowed gastric emptying is particularly relevant when considering anesthesia, as it can increase the risk of pulmonary aspiration—where stomach contents enter the lungs—during surgical procedures.

Hi Doctor AI provides telemedicine consultations. All treatments are prescribed by EU-licensed doctors after reviewing your medical history. We do not sell or ship medications—prescriptions can be used at any licensed pharmacy in the EU.

The Risks of GLP-1 Medications and Anesthesia

One of the primary concerns with GLP-1 medications in the context of anesthesia is their impact on gastric motility. By slowing down the rate at which the stomach empties, these drugs can lead to a higher volume of gastric contents at the time of surgery. During anesthesia, normal protective reflexes, such as gagging and coughing, are suppressed. If a patient vomits or regurgitates, there is an increased risk that stomach contents could be aspirated into the lungs, leading to aspiration pneumonitis or pneumonia—serious complications that can prolong hospital stays and increase morbidity.

Several factors can exacerbate this risk:

  • Emergency Surgeries: In emergency situations, there may not be sufficient time to adequately prepare the patient, including ensuring an empty stomach.
  • Obesity: Many patients taking GLP-1 medications are also obese, which is an independent risk factor for aspiration during anesthesia due to increased intra-abdominal pressure and altered gastroesophageal function.
  • Other Medications: Concomitant use of other medications that affect gastric motility or lower esophageal sphincter tone can further increase the risk.

Guidelines for Managing GLP-1 Medications Before Surgery

Given the potential risks, several medical societies have issued guidelines regarding the management of GLP-1 medications before surgical procedures. The American Society of Anesthesiologists (ASA) and other international bodies recommend that patients taking GLP-1 receptor agonists should consider the following:

  • Elective Surgeries: For elective surgeries, consider discontinuing GLP-1 medications at least one week prior to the procedure. This timeframe allows for the stomach to empty more effectively, reducing the risk of aspiration.
  • Individual Assessment: The decision to discontinue GLP-1 medications should be made on a case-by-case basis, considering the patient's overall health status, the type of surgery, and the urgency of the procedure.
  • Communication is Key: Patients must inform their anesthesiologist and surgeon about their use of GLP-1 medications. This information allows the medical team to make informed decisions about the anesthetic plan and take appropriate precautions.
  • Diabetes Management: For patients with diabetes, it's crucial to have a plan in place to manage blood sugar levels effectively while off GLP-1 medications. This may involve adjusting other diabetes medications or temporarily using insulin.

It's important to note that these guidelines are not definitive, and practices may vary among institutions. The ultimate decision should be based on a thorough evaluation of the patient's specific circumstances.

How Hi Doctor AI Helps

Hi Doctor AI offers a convenient and efficient way to manage your GLP-1 prescriptions and address any concerns related to surgical procedures. Our EU-licensed doctors can provide online consultations to discuss:

  • The risks and benefits of continuing or discontinuing GLP-1 medications before surgery.
  • Strategies for managing blood sugar levels while off GLP-1 medications (for diabetic patients).
  • Adjustments to your prescription schedule to align with surgical timelines.
  • Answer any questions you may have about your medication and its potential interactions with anesthesia.

With Hi Doctor AI, you can skip the waiting room and receive expert medical advice from the comfort of your own home. Our platform ensures that you have the information and support you need to make informed decisions about your health.

Ready to Get Started?

Ensure your safety and well-being by discussing your GLP-1 medication use with a qualified healthcare professional before undergoing any surgical procedure. Get your online consultation with Hi Doctor AI—EU-licensed doctors, 45€ consultation fee.

hi-doctor.ai Blog

GLP-1 Medications and Anesthesia: What You Need to Know